Paloma Partners Management CO Johnson & Johnson Call Options Transaction History

Paloma Partners Management CO

$1.66 Billion
Q1 2024

Call Options

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $10.3 Million - $10.8 Million	-66,351 Reduced 88.0%	9,049 $1.43 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $10.3 Million - $11.2 Million	70,400 Added 1408.0%	75,400 $11.8 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $778,750 - $872,400	5,000 New	5,000 $778,000
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $7.55 Million - $9.01 Million	50,000 New	50,000 $7.75 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $14.5 Million - $16 Million	-86,100 Reduced 95.45%	4,100 $728,000

Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $14.1 Million - $15.6 Million	90,200 New	90,200 $15.4 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $3.05 Million - $3.39 Million	-18,900 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $1.69 Million - $1.81 Million	10,600 Added 127.71%	18,900 $3.11 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $476,597 - $575,387	-3,700 Reduced 30.83%	8,300 $1.17 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $5.9 Million - $6.56 Million	-46,900 Reduced 79.63%	12,000 $1.68 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $2.92 Million - $3.43 Million	24,000 Added 68.77%	58,900 $8.14 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $2.51 Million - $2.77 Million	21,000 Added 151.08%	34,900 $4.24 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $2.36 Million - $2.59 Million	-18,000 Reduced 56.43%	13,900 $1.94 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $4.13 Million - $4.32 Million	31,900	31,900 $4.15 Million

Others Institutions Holding JNJ

# of Institutions

4,146

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account